Literature DB >> 8227024

Phosphorylation and active ATP hydrolysis are not required for SV40 T antigen hexamer formation.

I Reynisdóttir1, H E Lorimer, P N Friedman, E H Wang, C Prives.   

Abstract

ATP induces structural alterations in SV40 large T antigen and promotes changes in its interaction with the viral replication origin. We have analyzed nucleotide-induced changes in T antigen structure in the absence of origin DNA. Most preparations of immunopurified T antigen contain several discrete species ranging in size from monomers through oligomers larger than hexamers. The predominant species consist of monomers and dimers. Incubation of T antigen with ATP or dATP leads to a dramatic and rapid increase in the appearance of T antigen hexamers. Weakly and nonhydrolyzable analogs of ATP are effective as well, indicating that hexamer formation does not require active ATP hydrolysis. After incubation of T antigen with [gamma-35S]ATP, stable association of the labeled nucleotide with all detectable forms occurs. Removal of greater than 80% of the T antigen phosphate residues does not significantly affect the formation of T antigen hexamers, although changes in the distribution and mobility of the other species of T antigen are apparent. Furthermore, T antigen synthesized in and purified from Escherichia coli and, therefore, presumably un- or underphosphorylated, is capable of forming hexamers. Nucleotide-induced T antigen hexamer formation thus appears to require neither protein phosphorylation nor active ATP hydrolysis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8227024

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Peptides containing cyclin/Cdk-nuclear localization signal motifs derived from viral initiator proteins bind to DNA when unphosphorylated.

Authors:  Ronald J Kim; Stephanie Moine; Danielle K Reese; Peter A Bullock
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

2.  Dimerization of simian virus 40 T-antigen hexamers activates T-antigen DNA helicase activity.

Authors:  N V Smelkova; J A Borowiec
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

3.  Murine polyomavirus and simian virus 40 large T antigens produce different structural alterations in viral origin DNA.

Authors:  S Bhattacharyya; H E Lorimer; C Prives
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

4.  Sequence requirements for the assembly of simian virus 40 T antigen and the T-antigen origin binding domain on the viral core origin of replication.

Authors:  H Y Kim; B A Barbaro; W S Joo; A E Prack; K R Sreekumar; P A Bullock
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

5.  The simian virus 40 core origin contains two separate sequence modules that support T-antigen double-hexamer assembly.

Authors:  K R Sreekumar; A E Prack; D R Winters; B A Barbaro; P A Bullock
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

6.  Zinc-binding and protein-protein interactions mediated by the polyomavirus large T antigen zinc finger.

Authors:  P E Rose; B S Schaffhausen
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

7.  Mechanisms of simian virus 40 T-antigen activation by phosphorylation of threonine 124.

Authors:  D McVey; B Woelker; P Tegtmeyer
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

8.  A novel heterogeneous nuclear ribonucleoprotein-like protein interacts with NS1 of the minute virus of mice.

Authors:  C E Harris; R A Boden; C R Astell
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

9.  Preformed hexamers of SV40 T antigen are active in RNA and origin-DNA unwinding.

Authors:  Heike Uhlmann-Schiffler; Stephanie Seinsoth; Hans Stahl
Journal:  Nucleic Acids Res       Date:  2002-07-15       Impact factor: 16.971

10.  Polyomavirus large T antigen binds cooperatively to its multiple binding sites in the viral origin of DNA replication.

Authors:  Y C Peng; N H Acheson
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.